Cadence Neuroscience raises $15M for epilepsy treatment created at Mayo Clinic

Cadence chief scientific officer Doug Sheffield (left) and CEO Kent Leyde. (Cadence Photo)

Medical device startup Cadence Neuroscience raised $15 million to develop a therapy for the treatment of epilepsy. The Series A round was led by Jazz Venture Partners, and the company also received support from Mayo Clinic

This post was originally published on this site


Check out
%d bloggers like this: